U.S. medtech lobbies join forces to blaze trails in China

China flag

A pair of medical technology lobbying groups joined forces on a series of initiatives designed to reduce trade barriers between China and the U.S. and "harmonize international standards for medical devices."

The Medical Imaging & Technology Alliance and the Advanced Medical Technology Assn. last week led a 2-day standards workshop during the U.S.-China Joint Commission on Commerce and Trade Pharmaceuticals & Medical Device Subgroup meeting, according to a press release.

The meeting aimed to "increase the Chinese government’s familiarity with the standard and further expedite their transition process," according to a statement. The workshop was joined by representatives from North and South America as well as Europe and Asia.

China plays a feature role in many medical device companies’ emerging market strategies, including for industry titans Medtronic (NYSE:MDT) and Boston Scientific (NYSE:BSX).

Last month Medtronic VP VP Simon Li told the Chinese reporters that the world’s largest pure play medical device maker was looking to expand its portfolio in China through a series of mergers and acquisition deals, which will be the centerpiece of its strategy for the People’s Republic.

Late last week the device maker added a managing director from one of Asia’s largest hospital chains to its board of directors, and earlier this month Medtronic launched an international cardiovascular research initiative taking place in 9 emerging markets, including China. 

The lobbying groups convened last week to provide China’s Food & Drug Admin. expertise on IEC 60601-1, the latest edition of the internationally recognized standards for electrical medical equipment.

"The enhanced certainties and efficiencies inherent in China’s adoption of IEC 60601-1 3rd edition will yield significant benefits to patients and manufacturers," MITA executive Director Gail Rodriguez said in prepared remarks.

During the presentation MITA urged Chinese officials to include medical devices in the country’s 2013 manufacturing negotiations with the U.S. and AdvaMed called on the country to consider bumping in vitro diagnostics into a lower-risk category for regulatory purposes.

"China’s transition to the 3rd edition will usher in a more collaborative era of medical standards, driven by safety and international progress in technology," AdvaMed global strategy & analysis executive vice president Ralph Ives added.

If successful, the groups’ efforts in China could also prove a boon for Boston Scientific, Medtronic’s primary competitor in several business units, which has also significantly increased its focus on China.

Last July, the Natick, Mass.-based medical device company announced a 5-year, $150 million plan to expand Chinese commercial operations, including establishing a wholly owned manufacturing site and developing training centers for Chinese health care providers.

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply